1-8 of 8
Magnus Björkholm
Close
Sort by
Journal Articles

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Ola Landgren, M.D., Ph.D., Magnus Björkholm, MD, PhD, Malin L Hultcrantz, MD, Christian Kjellander, MD, Ingemar Turesson, MD, PhD, Erik Holmberg, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 945.
https://doi.org/10.1182/blood.V120.21.945.945
Published: 2012
Journal Articles

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005,

Malin L Hultcrantz, MD, Sally R Hinchliffe, Biostatistician, Sigurdur Y Kristinsson, M.D., Ph.D., Therese M-L Andersson, Biostatistician, Sandra Eloranta, Statistician, Åsa Rangert Derolf, MD, PhD, Jan Samuelsson, MD, PhD, Ola Landgren, MD, PhD, Paul W Dickman, Biostatistician, Paul Lambert, Biostatistician, Magnus Björkholm, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3855.
https://doi.org/10.1182/blood.V118.21.3855.3855
Published: 2011
Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4053.
https://doi.org/10.1182/blood.V116.21.4053.4053
Published: 2010
Journal Articles

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Christian Karl Kjellander, MD, Honar Cherif, MD, PhD, Magnus Björkholm, MD, PhD, Mats Kalin, Md, PhD, Christian G Giske, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4868.
https://doi.org/10.1182/blood.V116.21.4868.4868
Published: 2010
Journal Articles

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Clinical Trials & Observations
Erik Björck, Sara Ek, Ola Landgren, Mats Jerkeman, Mats Ehinger, Magnus Björkholm, Carl A. K. Borrebaeck, Anna Porwit-MacDonald, Magnus Nordenskjöld
Journal: Blood
Blood (2005) 105 (7): 2908–2915.
https://doi.org/10.1182/blood-2004-07-2721
Published: 2005
Journal Articles

Leukotriene B 4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells

Gudmundur Runarsson, Anquan Liu, Yilmaz Mahshid, Stina Feltenmark, Annika Pettersson, Eva Klein, Magnus Björkholm, Hans-Erik Claesson
Journal: Blood
Blood (2005) 105 (3): 1274–1279.
https://doi.org/10.1182/blood-2004-07-2546
Published: 2005
Journal Articles

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

Clinical Trials & Observations
Eva Ösby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm
Journal: Blood
Blood (2003) 101 (10): 3840–3848.
https://doi.org/10.1182/blood-2002-10-3238
Published: 2003
Journal Articles

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Clinical Trials & Observations
Jeanette Lundin, Eva Kimby, Magnus Björkholm, Per-Anders Broliden, Fredrik Celsing, Viktoria Hjalmar, Lars Möllgård, Peppy Rebello, Geoff Hale, Herman Waldmann, Håkan Mellstedt, Anders Österborg
Journal: Blood
Blood (2002) 100 (3): 768–773.
https://doi.org/10.1182/blood-2002-01-0159
Published: 2002